JP Morgan Chase
TNGX icon

JP Morgan Chase’s Tango Therapeutics TNGX Stock Holding History

JP Morgan Chase’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.3M Buy
1,418,193
+1,350,867
+2,006% +$33.4M ﹤0.01% 1535
2026
Q1 		$1.29M Buy
67,326
+10,491
+18% +$146K ﹤0.01% 4429
2025
Q4 		$504K Buy
56,835
+22,919
+68% +$197K ﹤0.01% 5047
2025
Q3 		$285K Sell
33,916
-32,759
-49% -$222K ﹤0.01% 5323
2025
Q2 		$341K Buy
66,675
+35,439
+113% +$87.6K ﹤0.01% 4969
2025
Q1 		$42.8K Sell
31,236
-77
-0.2% -$189 ﹤0.01% 5936
2024
Q4 		$96.8K Sell
31,313
-21,527
-41% -$100K ﹤0.01% 5770
2024
Q3 		$407K Buy
52,840
+1,281
+2% +$12.2K ﹤0.01% 5040
2024
Q2 		$442K Sell
51,559
-71,138
-58% -$550K ﹤0.01% 4754
2024
Q1 		$974K Buy
122,697
+72,894
+146% +$781K ﹤0.01% 4366
2023
Q4 		$493K Buy
49,803
+2,551
+5% +$22.1K ﹤0.01% 4806
2023
Q3 		$532K Buy
47,252
+7,624
+19% +$46.5K ﹤0.01% 4440
2023
Q2 		$132K Sell
39,628
-21,341
-35% -$76.8K ﹤0.01% 5329
2023
Q1 		$241K Buy
60,969
+10,980
+22% +$63.7K ﹤0.01% 4953
2022
Q4 		$363K Buy
49,989
+8,134
+19% +$57.2K ﹤0.01% 4717
2022
Q3 		$151K Sell
41,855
-7,472
-15% -$31.9K ﹤0.01% 5081
2022
Q2 		$224K Buy
49,327
+23,090
+88% +$140K ﹤0.01% 5021
2022
Q1 		$199K Sell
26,237
-6,298
-19% -$54.6K ﹤0.01% 5198
2021
Q4 		$357K Buy
32,535
+30,723
+1,696% +$369K ﹤0.01% 5029
2021
Q3 		$23K Buy
+1,812
New +$21.7K ﹤0.01% 6020
2020
Q4 		– Sell
-100,000
Closed -$1.02M – 5930
2020
Q3 		$1.02M Buy
+100,000
New +$1.02M ﹤0.01% 3632

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

JP Morgan Chase's TNGX Position: Q2 2026 in Review

JP Morgan Chase increased its Tango Therapeutics (TNGX) stake by 2,006% in Q2 2026, buying an estimated $33.4M and bringing the position to 1,418,193 shares worth $46.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

JP Morgan Chase first reported a position in TNGX in Q3 2020 and has held it in 21 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • JP Morgan Chase held 1,418,193 shares of Tango Therapeutics worth $46.3M as of Q2 2026.
  • JP Morgan Chase bought 1,350,867 Tango Therapeutics shares in Q2 2026, an estimated $33.4M.
  • Tango Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1535 holding.
  • JP Morgan Chase first reported a position in Tango Therapeutics in Q3 2020 and has held it in 21 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.